Bellus Health (TSX:BLU)(NASDAQ:BLU) is a $397.17 million clinical-stage biopharmaceutical - Growth

Bellus Health (TSX:BLU)(NASDAQ:BLU) is a $397.17 million clinical-stage biopharmaceutical company from Laval, Canada. It develops therapeutics for the treatment of chronic cough, chronic pruritus, and other hypersensitization disorders. The company’s lead drug candidate, BLU-5937, is now in phase two clinical trial. Bellus Health President and CEO Roberto Bellini anticipate a transformative year ahead following the significant progress with the clinical development of BLU-5937 over the past 12 months. Management believes its lead drug candidate has the potential to treat a wide range of hypersensitization-related conditions. Source: https://ca.finance.yahoo.com/news/2-tsx-stocks-could-return-133625109.html 

back
default-avatar-0

highlights

Mar 7, 2021
· POSITION CLOSED

13.45%

Position Return %

3.83

Price When Posted

0.51

Position Return

BLU

Bellus Health Inc

5.77

-0.02
-0.34%
Current Price

Bellus Health (TSX:BLU)(NASDAQ:BLU) is a $397.17 million clinical-stage biopharmaceutical - Growth

bullish
 

Bellus Health (TSX:BLU)(NASDAQ:BLU) is a $397.17 million clinical-stage biopharmaceutical company from Laval, Canada. It develops therapeutics for the treatment of chronic cough, chronic pruritus, and other hypersensitization disorders. The company’s lead drug candidate, BLU-5937, is now in phase two clinical trial.

Bellus Health President and CEO Roberto Bellini anticipate a transformative year ahead following the significant progress with the clinical development of BLU-5937 over the past 12 months. Management believes its lead drug candidate has the potential to treat a wide range of hypersensitization-related conditions.

 

Source: https://ca.finance.yahoo.com/news/2-tsx-stocks-could-return-133625109.html 

Comments

Write your comment....

Sign in to comment

read-time
< 1 min

4.21

Target Price

10/ 10

Confidence

2-6 Months

Timeframe
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

BLU Channel

Start new chat
next